A 52-year-old cardiologist sees an average of 15 patients daily with hypertension. Over the past year, she has prescribed antihypertensive medications from Pharmacos Inc. in 60% of her hypertensive patients, compared to 35% five years ago before accepting a consulting contract. The contract pays $50,000 annually for attending 12 monthly meetings to provide feedback on the company's drug development pipeline. She has disclosed this relationship in her institutional conflict-of-interest form and continues meeting all continuing medical education requirements. Her prescribing pattern for competing antihypertensives from other manufacturers has proportionally decreased. Pharmacologically, all agents are similarly effective for her patient population. Which of the following best describes the primary ethical concern with this arrangement?

1. A)Violation of the Sunshine Act because the consulting contract was not publicly reported
2. B)Breach of fiduciary duty requiring the physician to prioritize patient autonomy by refusing all industry relationships
3. C)An unconscious financial incentive that may compromise the physician's medical judgment despite disclosure and compliance with regulationsGABARITO
4. D)Illegal inducement under federal anti-kickback statutes prohibiting payments for prescribing referrals
5. E)Failure to obtain informed consent from patients regarding the potential bias in medication selection